Raised Plasma Levels of Asymmetric Dimethylarginine Are Associated with Pathological Type and Predict the Therapeutic Effect in Lupus Nephritis Patients Treated with Cyclophosphamide

• Main Authors: Li Zhang (Author), Kaichong Zhang (Author), Wei Dong (Author), Ruizhao Li (Author), Renwei Huang (Author), Hong Zhang (Author), Wanxin Shi (Author), Shuangxin Liu (Author), Zhuo Li (Author), Yuanhan Chen (Author), Zhiming Ye (Author), Xinling Liang (Author), Xueqing Yu (Author)
• Format: Book
• Published: Karger Publishers, 2020-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Lupus nephritis (LN) is one of the most serious complications of systemic lupus erythematosus (SLE). Asymmetric dimethylarginine (ADMA) has been associated with cardiovascular events in SLE patients and is a strong predictor of the progression of chronic kidney disease. However, whether...